Novavax

NVAX - Novavax • Dividends

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding DateValue (U$)Frequency
12/13/2007
0,106
Monthly
11/13/2007
0,106
Monthly
10/11/2007
0,106
Monthly
9/13/2007
0,106
Monthly
8/13/2007
0,106
Monthly
7/12/2007
0,106
Monthly

The latest dividend from NVAX was $0.106 per share (ex-dividend 12/13/2007). The dividend yield over the last 12 months is 0%.